Prospects of antigen-specific therapy in type 1 diabetes mellitus
Type 1 diabetes mellitus is commonly recognized as an autoimmune disease characterized by progressive destruction of pancreatic ?-beta-cells. Progress in diagnostics at preclinical stage is accompanied with active development of preventive measures. So far, there are no specific therapeutic agents a...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2012-12-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/5534 |
_version_ | 1797255241715941376 |
---|---|
author | Tatiana Vasil'evna Nikonova Yulia Viktorovna Alekseeva |
author_facet | Tatiana Vasil'evna Nikonova Yulia Viktorovna Alekseeva |
author_sort | Tatiana Vasil'evna Nikonova |
collection | DOAJ |
description | Type 1 diabetes mellitus is commonly recognized as an autoimmune disease characterized by progressive destruction of pancreatic ?-beta-cells. Progress in diagnostics at preclinical stage is accompanied with active development of preventive measures. So far, there are no specific therapeutic agents approved for clinical practice. However, ongoing large-scale studies have outlined some promising solutions, antigen-specific immunotherapy being one of them. |
first_indexed | 2024-03-08T15:21:48Z |
format | Article |
id | doaj.art-dcc7b58ce30f498f8bd52c9a5e94510c |
institution | Directory Open Access Journal |
issn | 2072-0351 2072-0378 |
language | English |
last_indexed | 2024-04-24T22:02:44Z |
publishDate | 2012-12-01 |
publisher | Endocrinology Research Centre |
record_format | Article |
series | Сахарный диабет |
spelling | doaj.art-dcc7b58ce30f498f8bd52c9a5e94510c2024-03-20T11:47:58ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782012-12-01154283210.14341/2072-0351-55345492Prospects of antigen-specific therapy in type 1 diabetes mellitusTatiana Vasil'evna Nikonova0Yulia Viktorovna Alekseeva1Endocrinology Research CentreEndocrinology Research CentreType 1 diabetes mellitus is commonly recognized as an autoimmune disease characterized by progressive destruction of pancreatic ?-beta-cells. Progress in diagnostics at preclinical stage is accompanied with active development of preventive measures. So far, there are no specific therapeutic agents approved for clinical practice. However, ongoing large-scale studies have outlined some promising solutions, antigen-specific immunotherapy being one of them.https://www.dia-endojournals.ru/jour/article/view/5534gad65hsp60diamyddiapep277diabetes mellitus type 1vaccinationgad65hsp60insulindiamyddiapep277 |
spellingShingle | Tatiana Vasil'evna Nikonova Yulia Viktorovna Alekseeva Prospects of antigen-specific therapy in type 1 diabetes mellitus Сахарный диабет gad65 hsp60 diamyd diapep277 diabetes mellitus type 1 vaccination gad65 hsp60 insulin diamyd diapep277 |
title | Prospects of antigen-specific therapy in type 1 diabetes mellitus |
title_full | Prospects of antigen-specific therapy in type 1 diabetes mellitus |
title_fullStr | Prospects of antigen-specific therapy in type 1 diabetes mellitus |
title_full_unstemmed | Prospects of antigen-specific therapy in type 1 diabetes mellitus |
title_short | Prospects of antigen-specific therapy in type 1 diabetes mellitus |
title_sort | prospects of antigen specific therapy in type 1 diabetes mellitus |
topic | gad65 hsp60 diamyd diapep277 diabetes mellitus type 1 vaccination gad65 hsp60 insulin diamyd diapep277 |
url | https://www.dia-endojournals.ru/jour/article/view/5534 |
work_keys_str_mv | AT tatianavasilevnanikonova prospectsofantigenspecifictherapyintype1diabetesmellitus AT yuliaviktorovnaalekseeva prospectsofantigenspecifictherapyintype1diabetesmellitus |